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OBJECTIVES We hypothesized that the plasma atrial natriuretic peptide (ANP) level reflects atrial
degenerative change and may predict the outcome of the maze procedure.
BACKGROUND Although a larger preoperative left atrial dimension and longer duration of atrial fibrillation
(AF) have been reported in patients with persistent AF than in those with sinus rhythm (SR),
these individual factors were not enough to predict the outcome of the maze procedure.
METHODS Preoperative plasma ANP levels were measured in consecutive 62 patients who underwent the
Kosakai’s modified maze procedure. Moreover, we performed histological and molecular
biological examinations in the resected left atrial tissues.
RESULTS The preoperative plasma ANP was lower in the AF group (n  13) than it was in the SR
group (n 49) (p 0.001). Multiple logistic regression analysis revealed that duration of AF
and plasma ANP were independently associated with postoperative cardiac rhythm. Among
41 patients with a higher plasma ANP or shorter duration of AF than the median value, SR
was restored in 95% of patients. In contrast, in 21 patients with a lower plasma ANP and a
longer duration of AF than the median value, SR was restored only in 48% of patients.
Histological examination revealed that the collagen volume in the left atrial tissue was higher
in AF than it was in SR and inversely correlated with plasma ANP. In addition, the
messenger RNA expressions of ANP, collagen type I and type III were lower in AF than they
were in SR.
CONCLUSIONS These results suggest that a combination of plasma ANP and/or duration of AF may predict
the success rate for the maze operation. Advanced atrial degenerative change may result in a
decrease of atrial ANP secretion. (J Am Coll Cardiol 2002;39:288–94) © 2002 by the
American College of Cardiology
The maze procedure effectively restores atrial fibrillation
(AF) to sinus rhythm (SR) and to atrial systole resulting in
the disappearance of palpitation, an improvement in hemo-
dynamics and the inhibition of thromboembolism (1–5).
However, recent studies revealed that the maze procedure
has several problems, which include larger operative inva-
sion due to longer aortic crossclamp time and cardiopulmo-
nary bypass time (6), body fluid retention due to reduced
atrial natriuretic peptide (ANP) secretion (7,8) and sick
sinus syndrome (9,10). Indeed, there are some patients
whose SR is not restored after the maze operation (6). Thus,
the time has come to discuss whether there is a desirable
indication for the maze procedure before a heart operation.
Previous studies have demonstrated that there might be a
low restore rate in patients who have a larger left atrial
systolic dimension (LAD) on echocardiography and longer
duration of AF (6). However, these individual parameters
were not enough to evaluate whether there is a desirable
indication for the maze procedure. A noninvasive biochem-
ical marker would be beneficial for this purpose. Atrial
natriuretic peptide is mainly synthesized in the atrium, and
a previous report suggested that ANP secretion becomes
insufficient in remarkable fibrosis in the atrium (11). In
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addition, a recent study reported that the patients who had
a longer duration of AF were reported to have lower plasma
ANP levels (12), suggesting that patients with a longer
duration of AF may have reduced ANP secretion presum-
ably due to the advanced atrial degenerative changes. We
hypothesized that the plasma ANP levels reflect the atrial
qualitative changes and may be a biochemical marker for
predicting the outcome of the maze procedure. To test this
hypothesis, in the present study we measured the preoper-
ative plasma ANP level in the patients who underwent the
maze procedure. Moreover, to explore the underlying mech-
anism of reduced ANP secretion, we performed histological
and molecular biological examinations in the resected left
atrial tissues.
METHODS
Patients. Sixty-two patients who underwent Kosakai’s
modified maze procedure were studied. Each subject pro-
vided informed consent for participation. All patients with
AF, as a result of organic heart disease, underwent the maze
procedure as previously reported (6). On the basis of the
postoperative rhythm (duration after surgery: 31.2  20.7
months), the subjects were divided into the SR group (n 
49) or the AF group (n  13).
Measurements of plasma ANP levels. Venous blood was
withdrawn at one day before operation. Immunoradiometric
assay was performed to measure plasma ANP levels (Shiono
RIA ANP kit; Shionogi Co., Ltd., Osaka, Japan) as
previously reported (13).
Histological examination. Sections 5 m thick of paraf-
finized left atrial appendage tissues were stained with
Masson’s trichrome to highlight collagen fibers. The colla-
gen volume fraction was determined by measuring the area
of stained tissue within a given field (14). In the resected left
atrial appendage, 10 fields were analyzed. We evaluated 30
randomly selected patients (SR group: n  24, AF group:
n  6).
Messenger RNA (mRNA) expressions of ANP, collagen
type I and type III in left atrial appendage tissue. To
obtain molecular biological evidence regarding the atrial
qualitative differences between the AF and SR groups,
resected left atrial tissues were frozen in liquid nitrogen and
stored at 80°C for Northern blot analysis in 31 patients
(SR group: n  26, AF group: n  5). A Pst I restriction
fragment of human ANP complementary DNA (cDNA)
corresponding to nucleotides 100 to 589 (15) was used as
the human ANP cDNA probe. The human collagen type I
and type III cDNA probes were synthesized by polymerase
chain reaction using the primers: collagen type I sense,
5-CAAGGTGTTGTGCGATGACG-3 collagen type I
antisense, 5-ATTCCTCCGGTTGATTTCTC-3; col-
lagen type III sense, 5-ATCCGTTCTCTGC-
GATGACATAATA-3 collagen type III antisense, 5-
GCCTGCGAGTCCTCCTACTGCTACT-3. RNA
extraction and Northern blot analyses were done using a
procedure previously described (15–17).
Statistics. Values are the mean  SD. Differences in
proportions were evaluated by chi-square analysis, unpaired
t test for continuous normally distributed variables and
Mann-Whitney U test for nonnormally distributed vari-
ables. The factors that related at the p  0.1 level were
selected as independent variable candidates for multiple
logistic regression analyses, which were used to evaluate the
independent contribution of clinical parameters to cardiac
rhythm after the operation. Differences were considered to
be statistically significant when the p value was  0.05.
Correlation coefficients were calculated using linear regres-
sion analysis.
RESULTS
Plasma ANP levels in the AF and SR groups. There were
no significant differences in age, gender, body surface area,
underlying heart diseases, operations or cardiothoracic ratio
(CTR) between the two groups. The LAD, the duration of
AF and preoperative plasma ANP level were significantly
larger, longer and lower in the AF group than they were in
the SR group (Table 1).
Histological examination data. The collagen volume frac-
tion in the left atrial appendage tissue was higher in the AF
group than it was in the SR group (Fig. 1). The collagen
volume fraction correlated negatively with the plasma ANP
levels (R  0.39, p  0.05) (Fig. 2A) and positively with
the duration of AF (R  0.62, p  0.001) (Fig. 2B).
The effects of plasma ANP and duration of AF on the
postoperative cardiac rhythm. Table 2 shows the results of
the multiple logistic regression analyses to assess the factors
independently contributing to the cardiac rhythm after the
operation (mean duration after surgery: 31.2  20.7
months). The LAD, duration of AF, CTR and plasma
ANP levels were added to this model. According to the
multiple logistic regression analyses, only the duration of
AF and plasma ANP levels were independent predictors of
cardiac rhythm after the maze operation. In 31 patients with
a higher plasma ANP than the median value (40 pg/ml),
SR was restored in 30 (97%) (Fig. 3). In 28 patients with a
shorter duration of AF than the median value (4.0 years),
SR was restored in 27 (96%) (Fig. 3). In contrast, in 21
patients with a lower or equal plasma ANP (40 pg/ml)
and with a longer or equal duration of AF (4.0 years), SR
was restored only in 10 (48%) (Fig. 3).
Abbreviations and Acronyms
AF  atrial fibrillation
ANP  atrial natriuretic peptide
cDNA  complementary DNA
CTR  cardiothoracic ratio
LAD  left atrial dimension
mRNA  messenger RNA
SR  sinus rhythm
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Combined assessment of plasma ANP level and duration
of AF versus duration of AF alone: prediction of persis-
tent AF after the maze operation. Table 3 shows the
sensitivity, specificity, accuracy and positive and negative
predictive value of the combined assessment of plasma ANP
level and duration of AF and the duration of AF alone for
predicting persistent AF after the maze operation. The
combined assessment had a significantly greater specificity
and accuracy than the duration of AF alone (80% vs. 55%,
81% vs. 63%, p  0.05, respectively), and there was a trend
toward an increase in positive predictive value for predicting
persistent AF after the operation.
The mRNA expression of ANP and collagen. As the
result of plasma ANP levels, the mRNA expression of ANP
in the left atrial appendage tissues was also significantly
lower (p  0.05) in the AF than it was in the SR (Fig. 4).
In contrast with the higher collagen volume fraction in AF
than in SR, the mRNA expressions of type I and III
collagen in the left atrial appendages were lower (both: p 
0.01) in the AF group than they were in the SR group (Fig. 4).
DISCUSSION
Comparison with other studies. An earlier study reported
that there were significant differences in LAD as deter-
mined by echocardiography and duration of AF between the
SR and AF groups after the maze procedure (6). In
addition, recent studies also demonstrated that duration of
AF, LAD and CTR were preoperative risk factors for
persistent AF after the maze operation (18–20). In the
present study, the patients with persistent AF after the maze
procedure had a longer history of AF and larger LAD
compared with the SR group. These results were consistent
with the previous studies and suggest that these parameters
might be useful for predicting the outcome of the maze
procedure. However, since these parameters had consider-
able overlap between the AF and SR groups and none had
Table 1. Comparison of Clinical Characteristics of Patients, Underlying Disease, Operation, Left
Atrial Dimension, Cardiothoracic Ratio, Duration of AF and ANP
AF (n  13) SR (n  49) p Value
Age (yrs) 57.9  8.3 56.7  8.3 0.644
Gender (male/female) 8/5 28/21 0.775
BSA (m2) 1.52  0.14 1.60  0.17 0.118
Underlying disease (No. of patients)
MS/MR/MSR/VSD/ASD (A) 3/2/8/0/0 (9) 9/17/19/1/3 (14) 0.455
Operation (No. of patients)
OMC/MVR/MVP/VSD/ASD closure 3/9/1/0/0 3/26/16/1/3 0.140
Medication (No. of patients) 0.358
Digoxin 13 37
Furosemide 10 37
Spironolactone 5 9
Nitrate 3 3
ACE inhibitor 2 13
Calcium antagonist 1 9
Beta-blocker 0 3
LAD (mm, preop) 63.2  10.7 56.3  8.2 0.014
CTR (%, preop) 62.5  7.8 58.7  6.0 0.068
Duration of AF (yrs, preop) 8.1  3.6 3.6  2.8 0.0001
Plasma ANP (pg/ml) 24.2  9.6 71.3  55.3 0.0009
Values are the mean  SD.
(A)  with aortic valve disease; ACE  angiotensin-converting enzyme; AF  atrial fibrillation; ANP  atrial natriuretic
peptide; ASD  atrial septal defect; BSA  body surface area; CTR  cardiothoracic ratio; LAD  left atrial dimension; MR
 mitral regurgitation; MS  mital stenosis; MSR  mitral stenosis and regurgitation; MVP  mitral valvuloplasty; MVR 
mitral valve replacement; OMC  open mitral commissurotomy; preop  preoperative; VSD  ventricular septal defect.
Figure 1. Masson’s trichrome staining of the excised left atrial appendages
under light microscopy and quantification of the collagen volume fraction
in the atrial fibrillation (AF) and sinus rhythm (SR) groups.
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cut-off points, it seems to be difficult to determine a
preoperative indication for the maze procedure using these
individual parameters.
Plasma ANP as information for predicting the outcome
of the maze procedure. In the present study, we measured
preoperative plasma ANP levels in patients who underwent
the maze procedure. Atrial natriuretic peptide is mainly
synthesized in the atrium, and its secretion is reduced in
remarkable fibrosis in the atrium (12). Therefore, we hy-
pothesized that plasma ANP reflects the atrial myocardial
qualitative change and might be beneficial for predicting the
outcome of the maze procedure. In the present study,
patients with a higher preoperative plasma ANP level (40
pg/ml) than the median value showed a high SR restoration
rate (97%), suggesting that high plasma ANP levels may be
a noninvasive biochemical marker for success in the maze
operation. In addition, to assess the factors independently
contributing to the cardiac rhythm after the operation,
multiple logistic regression analyses were performed. Ac-
cording to these analyses, only duration of AF and plasma
ANP level were independent predictors of cardiac rhythm
after the maze operation. The significant relationship be-
tween the outcome of the maze procedure and the duration
of AF was consistent with previous reports (6,20). In fact,
patients with a shorter duration of AF (4.0 years) than the
median value, irrespective of their ANP levels, showed a
high SR restoration rate, suggesting that a short duration of
AF is also a marker for success in the maze operation.
Furthermore, the combined assessment of plasma ANP
level and duration of AF had a significantly greater speci-
ficity and accuracy and a trend toward an increase in positive
predictive value compared with the duration of AF alone for
predicting the outcome of the maze operation. In fact,
patients with lower plasma ANP levels (40 pg/ml) and a
longer duration of AF (4.0 years) showed a low restora-
tion rate (48%), suggesting that the combination of a low
plasma ANP level and long duration of AF is predictive of
a low success rate for the maze procedure. Specifically, in the
patients with high ANP levels (50 pg/ml), SR was
completely restored in 29/29 (100%). Furthermore, among
the patients with a lower ANP (40 pg/ml) and with a
longer duration of AF history (8.0 years), SR was restored
only in 3/12 (25%). Thus, a high ANP level or short
duration of AF may predict a good outcome for the maze
procedure, whereas a low ANP with long duration of AF
may predict a lower rate of recovery to SR after the maze
procedure. Since recent studies revealed that the maze
procedure has several problems, which include greater
operative invasion (6), body fluid retention and sick sinus
syndrome (9,10), these parameters may help to determine
an indication for the maze procedure.
Figure 2. Correlations between collagen volume fraction and plasma atrial
natriuretic peptide (ANP) level (A) and duration of AF (B).
Table 2. Associations Between Cardiac Rhythm After the
Operation and Clinical Parameters by Multiple Logistic
Regression Analyses
Cardiac Rhythm After the Operation
Chi-Square df p Value
LAD 1.190 1 0.275
Duration of AF 4.717 1 0.030
CTR 0.0002 1 0.988
Plasma ANP 8.300 1 0.004
AF  atrial fibrillation; ANP  atrial natriuretic peptide; CTR  cardiothoracic
ratio; df  degrees of freedom; LAD  left atrial dimension.
Figure 3. Combined assessment of plasma atrial natriuretic peptide (ANP)
level and duration of atrial fibrillation (AF). SR  sinus rhythm.
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Underlying mechanism for reduced ANP in patients with
AF. A previous study reported that plasma ANP levels
were increased due to an atrial pressure elevation in patients
with supraventricular tachycardia and AF (21) and promptly
decreased after electrical cardioversion (22). Furthermore,
patients who had an increase in the plasma ANP levels from
rest to peak exercise before defibrillation had a better
outcome of electrical cardioversion (23). In addition, atrial
mechanical overload leads to an atrial qualitative change
resulting in the initiation and perpetuation of AF (24–26).
These findings suggest that patients with maintaining SR
after electrical cardioversion may have less atrial qualitative
change and that the ability of ANP secretion was reserved in
these patients. In addition, previous study demonstrated
that the plasma ANP levels were lower among patients with
AF of longer duration (11). This finding suggests that the
plasma ANP level also reflects the qualitative change of
atrial myocardium. However, there was no direct evidence,
which clarified the relationship between plasma ANP levels
and histological findings. In the present study, we per-
formed a histological examination in the excised left atrial
appendage tissues and demonstrated for the first time that
the collagen volume fraction was significantly increased in
the AF group compared with the SR group and that the
Table 3. Predictive Values Associating the Combination of ANP and Duration of AF and the
Duration of AF Alone With the Outcome of the Maze Operation
Sensitivity Specificity Accuracy
Positive
Predictive Value
Negative
Predictive Value
Duration of AF 12/13 (92%) 27/49 (55%) 39/62 (63%) 12/34 (35%) 27/28 (96%)
Plasma ANP and
duration of AF
11/13 (84%) 39/49 (80%) 50/62 (81%) 11/21 (52%) 39/41 (95%)
Fisher’s p value 0.9999 0.0171 0.0452 0.2658 0.9999
Cut-off values were 4.0 years and 40 pg/ml for AF duration and plasma ANP, respectively.
AF  atrial fibrillation; ANP  atrial natriuretic peptide.
Figure 4. Representative Northern blots showing collagen type I, type III and atrial natriuretic peptide (ANP) in the excised left atrial appendages in
patients with persistent atrial fibrillation after the maze procedure (AF group) and patients with sinus rhythm (SR group). Bar graph shows the summary
of findings of Northern blot analysis of atrial collagen type I, type III and ANP messenger RNA in the AF and SR groups.
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collagen volume fraction negatively correlated with the
plasma ANP level. Furthermore, we showed that the ANP
mRNA expression was significantly decreased in the AF
group compared with the SR group. Thus, the ability to
secrete ANP was reduced in the AF group presumably due
to the advanced histological and molecular biological
changes in the left atrial myocardium. Plasma ANP levels,
therefore, may reflect atrial qualitative change and provide
information for predicting the outcome of the maze proce-
dure. We also detected the reduced mRNA expressions of
collagen type I and III, although the collagen volume
fraction was significantly higher in left atrial appendage in
the AF group compared with the SR group. The exact
mechanism for the discrepancy between the reduced mRNA
expression and increased collagen volume is not known at
present; however, previous studies have shown that collagen
mRNA levels are higher in the active fibrosis tissue than
they are in inactive scar tissue (27). In myocardial infarct
tissue, mRNA expressions of collagen type I and III reached
peak at two to four days after myocardial infarction and
gradually decreased thereafter (27). The increase in types I
and III procollagen mRNA in infarcted myocardium was
followed by an increased collagen deposition, and it reaches
peak at day 2 to three weeks (27). Thus, mRNA expression
of collagen is often different from collagen volume fraction,
and it seems to depend on the time course. These results
suggest that atrial myocardium in the SR group is more
active in the fibrosis phase than that in AF group and that
atrial myocardium of the AF group may be the end stage of
AF.
Study limitations. There were relatively small numbers of
patients to prove the relationship between atrial degenera-
tive changes and plasma ANP levels in the present study.
Furthermore, we could not completely deny the possibility
that the reason for remaining AF may not only be due to the
advanced atrial degenerative change but also to the technical
difficulties of maze procedure in large atria. Further study is
required in a large number of patients in the future to
resolve these questions.
Conclusions. A high preoperative plasma ANP level or
short duration of AF may predict a high success rate for the
maze procedure, whereas a low plasma ANP level with
longer duration of AF may predict a low success rate.
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